Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemodialysis vascular access dysfunction from basic biology to clinical intervention.

Prabir Roy-Chaudhury1, Burnett S Kelly, Ashwath Narayana

  • 1University of Cincinnati Medical Center, Cincinnati, OH, USA.

Advances in Renal Replacement Therapy
|June 27, 2002
PubMed
Summary

Venous neointimal hyperplasia causes hemodialysis vascular access dysfunction, leading to hospitalization and high costs. Understanding its pathogenesis is key to developing effective local therapies for this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient Centered Technologies to Improve Hemodialysis Vascular Access Cannulation.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Promoting Equity From Within: Eliminating Hierarchy and Bias in Transplant Teams.

Transplantation·2026
Same author

Biofunctionalized Vascular Access Graft Improves Patency and Endothelialization in a Porcine Arteriovenous Model.

Journal of functional biomaterials·2026
Same author

Safety and Effectiveness of the Wrapsody Cell-Impermeable Endoprosthesis to Treat Dysfunctional Arteriovenous Grafts: Results from the Nonrandomized Arm of the WAVE Trial.

Journal of vascular and interventional radiology : JVIR·2026
Same author

One-Year Clinical Outcomes from the Randomized Controlled Arm of the Wrapsody Arteriovenous Access Efficacy (WAVE) Trial.

Journal of vascular and interventional radiology : JVIR·2026
Same author

Bulk RNA Sequencing Reveals Signature Differences in Key Cell Signaling Pathways Between Porcine Venous and Arterial Smooth Muscle Cells.

International journal of molecular sciences·2025

Area of Science:

  • Vascular Biology
  • Nephrology
  • Surgical Innovation

Background:

  • Hemodialysis vascular access dysfunction is a significant clinical problem, causing morbidity and costing over $1 billion annually.
  • Venous stenosis and thrombosis, driven by venous neointimal hyperplasia, are primary causes of access failure.
  • Current therapeutic options for this condition are limited due to an incomplete understanding of its underlying mechanisms.

Purpose of the Study:

  • To review the histological characteristics of venous neointimal hyperplasia in human and animal models.
  • To identify potential therapeutic targets within the neointimal hyperplasia lesion.
  • To propose polytetrafluoroethylene (PTFE) dialysis grafts as a model for testing novel local therapies.

Main Methods:

  • Histological examination of human venous neointimal hyperplasia specimens.

Related Experiment Videos

  • Analysis of a pig model exhibiting similar pathological features.
  • Review of existing literature on the pathogenesis and potential treatments.

    • Main Results:

    • Venous neointimal hyperplasia is characterized by smooth muscle cell proliferation, angiogenesis, and extracellular matrix accumulation.
    • These cellular and matrix components represent potential targets for therapeutic intervention.
    • The pig model effectively recapitulates key features of human venous neointimal hyperplasia.

    Conclusions:

    • A deeper understanding of venous neointimal hyperplasia pathogenesis is crucial for developing effective treatments.
    • Polytetrafluoroethylene grafts offer a viable clinical model for evaluating localized therapies.
    • Future research should focus on targeting specific cellular and molecular pathways involved in neointimal hyperplasia.